 Richard Radcliffe
Concepts (305)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ethanol | 27 | 2020 | 538 | 4.160 |
Why?
| | Quantitative Trait Loci | 10 | 2020 | 305 | 2.770 |
Why?
| | Drug Tolerance | 10 | 2020 | 79 | 2.540 |
Why?
| | Alcohol Drinking | 8 | 2017 | 651 | 1.770 |
Why?
| | Alcoholism | 15 | 2020 | 713 | 1.680 |
Why?
| | Chromosome Mapping | 18 | 2020 | 487 | 1.460 |
Why?
| | Mice, Inbred Strains | 24 | 2020 | 396 | 1.210 |
Why?
| | Reflex, Righting | 4 | 2018 | 10 | 1.190 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 2 | 2016 | 43 | 0.960 |
Why?
| | Receptors, Neurotensin | 7 | 2006 | 12 | 0.880 |
Why?
| | Motor Activity | 11 | 2010 | 640 | 0.880 |
Why?
| | Sleep | 6 | 2016 | 632 | 0.820 |
Why?
| | Quantitative Trait, Heritable | 9 | 2017 | 116 | 0.820 |
Why?
| | Central Nervous System Depressants | 8 | 2011 | 81 | 0.740 |
Why?
| | Mice | 51 | 2020 | 14872 | 0.730 |
Why?
| | Methamphetamine | 2 | 2011 | 51 | 0.710 |
Why?
| | Fear | 7 | 2011 | 293 | 0.660 |
Why?
| | Locomotion | 3 | 2016 | 80 | 0.650 |
Why?
| | Animals | 62 | 2020 | 31709 | 0.650 |
Why?
| | Genotype | 14 | 2020 | 1760 | 0.630 |
Why?
| | Behavior, Animal | 7 | 2017 | 458 | 0.610 |
Why?
| | Consummatory Behavior | 1 | 2017 | 5 | 0.580 |
Why?
| | Species Specificity | 9 | 2017 | 542 | 0.500 |
Why?
| | Rats, Inbred Strains | 6 | 2007 | 362 | 0.490 |
Why?
| | Mice, Inbred DBA | 11 | 2011 | 174 | 0.480 |
Why?
| | Genome | 1 | 2016 | 271 | 0.460 |
Why?
| | Gene Expression Profiling | 5 | 2017 | 1518 | 0.450 |
Why?
| | Darkness | 1 | 2013 | 23 | 0.430 |
Why?
| | Migraine with Aura | 1 | 2013 | 10 | 0.430 |
Why?
| | Genetic Predisposition to Disease | 7 | 2018 | 2087 | 0.430 |
Why?
| | Phenotype | 12 | 2017 | 2797 | 0.420 |
Why?
| | Mice, Inbred C57BL | 19 | 2018 | 4694 | 0.420 |
Why?
| | Crosses, Genetic | 5 | 2007 | 139 | 0.420 |
Why?
| | Conditioning, Classical | 4 | 2003 | 87 | 0.420 |
Why?
| | Neurotensin | 6 | 2001 | 11 | 0.410 |
Why?
| | Brain Chemistry | 6 | 2009 | 115 | 0.400 |
Why?
| | Rats | 12 | 2017 | 4958 | 0.390 |
Why?
| | Dopamine Agents | 1 | 2011 | 14 | 0.380 |
Why?
| | Amphetamine-Related Disorders | 1 | 2011 | 28 | 0.370 |
Why?
| | Basal Ganglia | 1 | 2011 | 44 | 0.370 |
Why?
| | Genetic Markers | 5 | 2009 | 320 | 0.370 |
Why?
| | Hypnotics and Sedatives | 3 | 2018 | 134 | 0.360 |
Why?
| | Recombination, Genetic | 3 | 1998 | 176 | 0.350 |
Why?
| | Brain | 9 | 2020 | 2371 | 0.340 |
Why?
| | Central Nervous System Stimulants | 1 | 2011 | 139 | 0.340 |
Why?
| | Male | 38 | 2020 | 55609 | 0.330 |
Why?
| | Disease Models, Animal | 4 | 2018 | 3535 | 0.330 |
Why?
| | Breeding | 2 | 2006 | 55 | 0.330 |
Why?
| | Alcohol-Induced Disorders, Nervous System | 1 | 2009 | 6 | 0.330 |
Why?
| | High-Throughput Nucleotide Sequencing | 3 | 2018 | 439 | 0.320 |
Why?
| | Mice, 129 Strain | 3 | 2016 | 75 | 0.320 |
Why?
| | Dopamine | 1 | 2011 | 236 | 0.320 |
Why?
| | Transcriptome | 2 | 2017 | 726 | 0.310 |
Why?
| | Reflex | 5 | 2007 | 64 | 0.310 |
Why?
| | MicroRNAs | 4 | 2018 | 600 | 0.290 |
Why?
| | Alcohol-Related Disorders | 1 | 2009 | 113 | 0.290 |
Why?
| | Dose-Response Relationship, Drug | 11 | 2016 | 1842 | 0.290 |
Why?
| | Models, Animal | 2 | 2010 | 344 | 0.280 |
Why?
| | Databases, Genetic | 2 | 2017 | 206 | 0.280 |
Why?
| | Selection, Genetic | 3 | 2007 | 242 | 0.250 |
Why?
| | Sequence Analysis, RNA | 3 | 2018 | 386 | 0.250 |
Why?
| | Haplotypes | 2 | 2006 | 448 | 0.240 |
Why?
| | Behavioral Sciences | 1 | 2004 | 9 | 0.240 |
Why?
| | Animals, Laboratory | 1 | 2004 | 13 | 0.230 |
Why?
| | Neurosciences | 1 | 2004 | 20 | 0.230 |
Why?
| | Animals, Congenic | 2 | 2017 | 9 | 0.230 |
Why?
| | Cerebellum | 5 | 2007 | 200 | 0.220 |
Why?
| | Receptors, GABA-A | 4 | 2018 | 82 | 0.210 |
Why?
| | Exome | 2 | 2014 | 200 | 0.200 |
Why?
| | Cues | 1 | 2004 | 300 | 0.200 |
Why?
| | Postural Balance | 2 | 2001 | 183 | 0.190 |
Why?
| | Pro-Opiomelanocortin | 2 | 1998 | 17 | 0.190 |
Why?
| | Prefrontal Cortex | 2 | 2011 | 262 | 0.190 |
Why?
| | Prealbumin | 2 | 2013 | 22 | 0.170 |
Why?
| | Transcription, Genetic | 2 | 2018 | 1313 | 0.170 |
Why?
| | Association Learning | 1 | 2000 | 60 | 0.170 |
Why?
| | Signal Transduction | 2 | 2011 | 4516 | 0.160 |
Why?
| | Esomeprazole | 1 | 2018 | 6 | 0.160 |
Why?
| | beta-Endorphin | 1 | 1998 | 7 | 0.160 |
Why?
| | Biomedical Research | 1 | 2004 | 585 | 0.160 |
Why?
| | Female | 18 | 2020 | 59523 | 0.150 |
Why?
| | Proton Pump Inhibitors | 1 | 2018 | 96 | 0.150 |
Why?
| | Chromosomes, Mammalian | 2 | 2007 | 26 | 0.140 |
Why?
| | Sex Factors | 2 | 2016 | 1715 | 0.140 |
Why?
| | Hippocampus | 2 | 2018 | 693 | 0.140 |
Why?
| | Central Nervous System | 1 | 1998 | 235 | 0.130 |
Why?
| | Environment | 1 | 1998 | 332 | 0.130 |
Why?
| | Mice, Knockout | 5 | 2016 | 2570 | 0.130 |
Why?
| | Lung Neoplasms | 5 | 2010 | 2177 | 0.130 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 1996 | 54 | 0.130 |
Why?
| | Rotarod Performance Test | 2 | 2006 | 17 | 0.130 |
Why?
| | Mutation | 3 | 2013 | 3346 | 0.120 |
Why?
| | Animals, Inbred Strains | 1 | 2015 | 7 | 0.120 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2017 | 1880 | 0.120 |
Why?
| | Protein Kinase C | 2 | 2006 | 273 | 0.120 |
Why?
| | Databases, Nucleic Acid | 1 | 2014 | 31 | 0.120 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 2 | 2018 | 180 | 0.120 |
Why?
| | Models, Genetic | 1 | 2017 | 562 | 0.110 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2006 | 740 | 0.110 |
Why?
| | Inositol Phosphates | 1 | 1993 | 23 | 0.110 |
Why?
| | Piperazines | 1 | 1996 | 309 | 0.110 |
Why?
| | 3' Untranslated Regions | 1 | 2014 | 129 | 0.110 |
Why?
| | Tyrosine 3-Monooxygenase | 2 | 2011 | 68 | 0.110 |
Why?
| | Phosphatidylinositols | 1 | 1993 | 54 | 0.110 |
Why?
| | Enkephalins | 1 | 2013 | 13 | 0.110 |
Why?
| | Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2013 | 9 | 0.110 |
Why?
| | Genetic Association Studies | 1 | 2015 | 339 | 0.110 |
Why?
| | Genomics | 1 | 2017 | 635 | 0.110 |
Why?
| | DNA Copy Number Variations | 1 | 2014 | 154 | 0.110 |
Why?
| | Corpus Striatum | 2 | 2006 | 126 | 0.100 |
Why?
| | Myosins | 1 | 2013 | 126 | 0.100 |
Why?
| | Sodium Chloride | 1 | 2013 | 136 | 0.100 |
Why?
| | Receptors, Neurotransmitter | 1 | 1992 | 15 | 0.100 |
Why?
| | Mesencephalon | 3 | 2006 | 57 | 0.100 |
Why?
| | Gastrointestinal Microbiome | 1 | 2018 | 501 | 0.100 |
Why?
| | Protein Precursors | 1 | 2013 | 119 | 0.100 |
Why?
| | RNA, Messenger | 5 | 2018 | 2553 | 0.100 |
Why?
| | Butylated Hydroxytoluene | 2 | 2002 | 31 | 0.100 |
Why?
| | Proteomics | 1 | 2017 | 836 | 0.100 |
Why?
| | 3,4-Dihydroxyphenylacetic Acid | 1 | 2011 | 17 | 0.100 |
Why?
| | Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2011 | 8 | 0.090 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 228 | 0.090 |
Why?
| | Long-Term Potentiation | 2 | 2011 | 145 | 0.090 |
Why?
| | Synaptic Potentials | 1 | 2011 | 17 | 0.090 |
Why?
| | Mice, Inbred A | 1 | 2010 | 45 | 0.090 |
Why?
| | Stress, Psychological | 1 | 2018 | 944 | 0.090 |
Why?
| | Nucleus Accumbens | 3 | 2006 | 124 | 0.090 |
Why?
| | Ataxia | 2 | 2009 | 35 | 0.090 |
Why?
| | Tumor Suppressor Proteins | 1 | 2013 | 282 | 0.090 |
Why?
| | Drug-Seeking Behavior | 1 | 2010 | 22 | 0.090 |
Why?
| | Injections, Intraperitoneal | 2 | 2006 | 99 | 0.090 |
Why?
| | Mice, Inbred C3H | 1 | 2010 | 239 | 0.090 |
Why?
| | Software | 1 | 2014 | 530 | 0.090 |
Why?
| | Sleep Stages | 1 | 1990 | 61 | 0.090 |
Why?
| | Polymorphism, Genetic | 1 | 2013 | 610 | 0.080 |
Why?
| | Time Factors | 3 | 2011 | 6116 | 0.080 |
Why?
| | Genes, ras | 1 | 2010 | 91 | 0.080 |
Why?
| | Body Temperature Regulation | 1 | 1990 | 72 | 0.080 |
Why?
| | Epistasis, Genetic | 1 | 2010 | 67 | 0.080 |
Why?
| | Arousal | 1 | 1990 | 152 | 0.080 |
Why?
| | Down-Regulation | 1 | 2011 | 594 | 0.080 |
Why?
| | Radioimmunoassay | 4 | 2001 | 162 | 0.080 |
Why?
| | Putamen | 2 | 2006 | 14 | 0.070 |
Why?
| | Alcoholic Intoxication | 2 | 2006 | 62 | 0.070 |
Why?
| | Fibrosarcoma | 1 | 2008 | 20 | 0.070 |
Why?
| | Time and Motion Studies | 2 | 1998 | 20 | 0.070 |
Why?
| | Neuronal Plasticity | 2 | 2001 | 209 | 0.070 |
Why?
| | Butyrates | 1 | 2008 | 53 | 0.070 |
Why?
| | Learning | 1 | 2011 | 350 | 0.070 |
Why?
| | Erythropoietin | 1 | 2008 | 72 | 0.070 |
Why?
| | Hypothermia | 2 | 2006 | 38 | 0.070 |
Why?
| | Angiogenesis Inhibitors | 1 | 2009 | 214 | 0.070 |
Why?
| | Neovascularization, Pathologic | 1 | 2009 | 281 | 0.070 |
Why?
| | Protein Engineering | 1 | 2008 | 98 | 0.070 |
Why?
| | Pneumonia | 2 | 2002 | 568 | 0.070 |
Why?
| | Gene Frequency | 1 | 2007 | 477 | 0.070 |
Why?
| | Cocaine | 3 | 1993 | 153 | 0.070 |
Why?
| | Reaction Time | 1 | 2007 | 376 | 0.070 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2006 | 270 | 0.060 |
Why?
| | Body Temperature | 1 | 2005 | 208 | 0.060 |
Why?
| | Organ Specificity | 3 | 1997 | 268 | 0.060 |
Why?
| | Electroshock | 1 | 2004 | 134 | 0.060 |
Why?
| | Age Factors | 1 | 2011 | 2894 | 0.060 |
Why?
| | Analysis of Variance | 2 | 1998 | 1226 | 0.060 |
Why?
| | Acoustic Stimulation | 1 | 2004 | 314 | 0.050 |
Why?
| | Adenocarcinoma | 1 | 2009 | 795 | 0.050 |
Why?
| | Humans | 8 | 2016 | 114709 | 0.050 |
Why?
| | Gene Deletion | 1 | 2003 | 356 | 0.050 |
Why?
| | Pentobarbital | 1 | 2001 | 16 | 0.050 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 1996 | 470 | 0.050 |
Why?
| | Interleukin-10 | 1 | 2003 | 299 | 0.050 |
Why?
| | Haloperidol | 1 | 2001 | 35 | 0.050 |
Why?
| | Neurons | 2 | 2007 | 1280 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2006 | 1796 | 0.050 |
Why?
| | Receptors, Kainic Acid | 1 | 2001 | 10 | 0.050 |
Why?
| | Memory | 1 | 2002 | 211 | 0.050 |
Why?
| | RNA Editing | 1 | 2001 | 20 | 0.050 |
Why?
| | Aging | 1 | 2010 | 1618 | 0.050 |
Why?
| | Mice, Congenic | 1 | 2000 | 21 | 0.050 |
Why?
| | Models, Biological | 1 | 2008 | 1621 | 0.040 |
Why?
| | Antipsychotic Agents | 1 | 2001 | 184 | 0.040 |
Why?
| | Kinetics | 2 | 1993 | 1551 | 0.040 |
Why?
| | Restraint, Physical | 1 | 2018 | 67 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2003 | 1140 | 0.040 |
Why?
| | GABA-A Receptor Antagonists | 1 | 2018 | 14 | 0.040 |
Why?
| | Ribonucleases | 1 | 1998 | 52 | 0.040 |
Why?
| | Gene Expression Regulation | 3 | 2018 | 2320 | 0.040 |
Why?
| | Carrier Proteins | 2 | 1992 | 695 | 0.040 |
Why?
| | Random Allocation | 1 | 2018 | 335 | 0.040 |
Why?
| | Seizures | 1 | 2001 | 340 | 0.040 |
Why?
| | Synapses | 1 | 2001 | 331 | 0.040 |
Why?
| | RNA, Bacterial | 1 | 2018 | 174 | 0.040 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2017 | 43 | 0.040 |
Why?
| | Ribosomal Proteins | 1 | 2017 | 70 | 0.040 |
Why?
| | Naltrexone | 1 | 1998 | 83 | 0.040 |
Why?
| | Systems Biology | 1 | 2017 | 54 | 0.040 |
Why?
| | Gene Expression | 2 | 2018 | 1421 | 0.040 |
Why?
| | Narcotic Antagonists | 1 | 1998 | 136 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2018 | 485 | 0.030 |
Why?
| | Microinjections | 1 | 1996 | 76 | 0.030 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 156 | 0.030 |
Why?
| | Binding, Competitive | 1 | 1996 | 193 | 0.030 |
Why?
| | Carcinogens | 2 | 2010 | 103 | 0.030 |
Why?
| | Receptors, Drug | 2 | 1992 | 12 | 0.030 |
Why?
| | Regression Analysis | 1 | 1998 | 945 | 0.030 |
Why?
| | Emotions | 1 | 1999 | 472 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 1998 | 723 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2014 | 2711 | 0.030 |
Why?
| | Linear Models | 1 | 2017 | 768 | 0.030 |
Why?
| | Comparative Genomic Hybridization | 1 | 2014 | 28 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2006 | 923 | 0.030 |
Why?
| | Carbachol | 1 | 1993 | 21 | 0.030 |
Why?
| | Inositol | 1 | 1993 | 23 | 0.030 |
Why?
| | Histamine H1 Antagonists | 1 | 1993 | 28 | 0.030 |
Why?
| | Second Messenger Systems | 1 | 1993 | 32 | 0.030 |
Why?
| | Hydrolysis | 1 | 1993 | 173 | 0.030 |
Why?
| | Membrane Lipids | 1 | 1993 | 87 | 0.030 |
Why?
| | Urethane | 2 | 2003 | 41 | 0.030 |
Why?
| | Calcium | 2 | 2001 | 1108 | 0.030 |
Why?
| | Adolescent | 1 | 2010 | 17855 | 0.030 |
Why?
| | Piperidines | 1 | 1993 | 160 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2014 | 523 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 2 | 2007 | 2218 | 0.020 |
Why?
| | Phospholipids | 1 | 1993 | 197 | 0.020 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2014 | 196 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2017 | 1177 | 0.020 |
Why?
| | Amnesia | 1 | 2011 | 42 | 0.020 |
Why?
| | Depression, Chemical | 1 | 1990 | 22 | 0.020 |
Why?
| | Tissue Extracts | 1 | 1990 | 20 | 0.020 |
Why?
| | Base Sequence | 1 | 2014 | 2114 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2014 | 2785 | 0.020 |
Why?
| | In Situ Nick-End Labeling | 1 | 2009 | 119 | 0.020 |
Why?
| | Immunoblotting | 1 | 2009 | 283 | 0.020 |
Why?
| | Microvessels | 1 | 2009 | 68 | 0.020 |
Why?
| | Glycosylation | 1 | 2008 | 130 | 0.020 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2007 | 28 | 0.020 |
Why?
| | STAT3 Transcription Factor | 1 | 2009 | 173 | 0.020 |
Why?
| | Silymarin | 1 | 2009 | 194 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 916 | 0.020 |
Why?
| | Electrophysiology | 1 | 2007 | 201 | 0.020 |
Why?
| | Phosphorylation | 1 | 2011 | 1569 | 0.020 |
Why?
| | Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2006 | 11 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 797 | 0.020 |
Why?
| | Potassium Channels, Tandem Pore Domain | 1 | 2006 | 12 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2006 | 47 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2007 | 502 | 0.020 |
Why?
| | Receptors, Steroid | 1 | 2006 | 47 | 0.020 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2006 | 61 | 0.020 |
Why?
| | Myelin Proteolipid Protein | 1 | 2006 | 61 | 0.020 |
Why?
| | Synaptic Transmission | 1 | 2007 | 227 | 0.020 |
Why?
| | DNA Primers | 1 | 2006 | 510 | 0.020 |
Why?
| | NF-kappa B | 1 | 2009 | 641 | 0.020 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2006 | 192 | 0.010 |
Why?
| | Neoplasm Proteins | 1 | 2008 | 385 | 0.010 |
Why?
| | Reference Values | 1 | 2006 | 743 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2008 | 1230 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2009 | 1629 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 1879 | 0.010 |
Why?
| | Computer Simulation | 1 | 2008 | 873 | 0.010 |
Why?
| | Homozygote | 1 | 2003 | 187 | 0.010 |
Why?
| | Heterozygote | 1 | 2003 | 251 | 0.010 |
Why?
| | Discrimination Learning | 1 | 2002 | 47 | 0.010 |
Why?
| | Sex Distribution | 1 | 2003 | 337 | 0.010 |
Why?
| | Nerve Tissue Proteins | 1 | 2006 | 530 | 0.010 |
Why?
| | Reflex, Startle | 1 | 2002 | 57 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1143 | 0.010 |
Why?
| | Methylcholanthrene | 1 | 2002 | 18 | 0.010 |
Why?
| | Lod Score | 1 | 2002 | 65 | 0.010 |
Why?
| | Macrophages | 1 | 2009 | 1263 | 0.010 |
Why?
| | Disease Susceptibility | 1 | 2003 | 316 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2009 | 2187 | 0.010 |
Why?
| | Cytokines | 1 | 2009 | 1841 | 0.010 |
Why?
| | Perforant Pathway | 1 | 2001 | 2 | 0.010 |
Why?
| | Kainic Acid | 1 | 2001 | 31 | 0.010 |
Why?
| | Alleles | 1 | 2003 | 789 | 0.010 |
Why?
| | Dentate Gyrus | 1 | 2001 | 30 | 0.010 |
Why?
| | Flunitrazepam | 1 | 2000 | 2 | 0.010 |
Why?
| | Tritium | 1 | 2000 | 66 | 0.010 |
Why?
| | Mice, Mutant Strains | 1 | 2001 | 271 | 0.010 |
Why?
| | RNA | 1 | 2006 | 809 | 0.010 |
Why?
| | Anti-Anxiety Agents | 1 | 2000 | 42 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2000 | 256 | 0.010 |
Why?
| | Apoptosis | 1 | 2009 | 2363 | 0.010 |
Why?
| | Transgenes | 1 | 2000 | 170 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2006 | 1314 | 0.010 |
Why?
| | Body Weight | 1 | 2003 | 869 | 0.010 |
Why?
| | Gene Dosage | 1 | 1999 | 129 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2006 | 2765 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2001 | 1016 | 0.010 |
Why?
| | Transcription Factors | 1 | 2006 | 1528 | 0.010 |
Why?
| | Genes, Dominant | 1 | 1997 | 94 | 0.010 |
Why?
| | Binding Sites | 1 | 2001 | 1168 | 0.010 |
Why?
| | Chromosomes | 1 | 1997 | 85 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 1999 | 1144 | 0.010 |
Why?
| | Genetic Linkage | 1 | 1997 | 294 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2000 | 1950 | 0.010 |
Why?
| | Caudate Nucleus | 1 | 1993 | 14 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2001 | 3886 | 0.010 |
Why?
| | Self Administration | 1 | 1993 | 122 | 0.010 |
Why?
| | Hypothalamus | 1 | 1993 | 147 | 0.010 |
Why?
| | Prosencephalon | 1 | 1992 | 45 | 0.010 |
Why?
| | Pharmacogenetics | 1 | 1993 | 149 | 0.010 |
Why?
| | Hypnosis | 1 | 1992 | 9 | 0.010 |
Why?
| | Stereotyped Behavior | 1 | 1991 | 19 | 0.010 |
Why?
| | Cell Membrane | 1 | 1992 | 680 | 0.000 |
Why?
|
|
Radcliffe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|